Skip to main content

Semaglutide and vision loss A new concern for NAION risk

Literature

About the CPD Course

Semaglutide, a widely prescribed GLP-1 receptor agonist, may be linked to increased risk of non-arteritic anterior ischemic optic neuropathy. While some large studies suggest modest long-term risk, findings remain inconsistent and observational. Ophthalmologists should stay vigilant, counsel at-risk patients, and await prospective research for clearer guidance.

Receive more information

CPD Provider

Pinpoint Scotland

Pinpoint Scotland

Pinpoint Scotland is a family run business, which since 1973 has specialised in publishing and direct mail services. As well as our own publications, we offer Direct Mail Services, and a full Design and Publishing Service, which can include magazines, brochures, annual reports and corporate branding. With sales, subscriptions, editorial, design, production and direct mail services all under roof, we have the unique ability to take a project from start to finish, ensuring quality and continuity.
View Profile

CPD Subsectors

Beauty & Cosmetic
Medical
Broadcasting & Publishing